The role of naloxone in out-of-hospital cardiac arrest management: a call for integration into Advanced Cardiac Life Support protocols

Opioid overdose has become a major contributor to out-of-hospital cardiac arrest (OHCA), necessitating an evaluation of current resuscitation strategies.The frontline treatment for opioid overdose is naloxone, a competitive opioid receptor antagonist.It is established in reversing opioid-induced respiratory depression, but there is a lack of quantified analysis of its efficacy in cardiac arrest scenarios.This study evaluates naloxone's role in OHCA management and its potential integration into Advanced Cardiac Life Support (ACLS) protocols from a systemic perspective.Evidence suggests that naloxone administration in suspected opioid-induced OHCA may improve ROSC and survival to hospital discharge.However, variability in opioid potency, delayed recognition of opioid toxicity, and limited data on naloxone's interaction with ACLS drugs, such as epinephrine, present challenges to implementation; moreover, a lack of clear protocols and algorithms for opioid-induced OHCA prevents a clear system problem.Integrating naloxone into ACLS protocols could enhance resuscitation outcomes in opioid-related OHCA.Further research is needed to refine dosing strategies, evaluate its impact on long-term neurological recovery, and optimize emergency response frameworks.Policy development should focus on expanding access, training EMS personnel, and ensuring effective bystander intervention.